期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (6)
Introduction Hyponatremia is a common electrolyte disturbance in critically ill patients. Management of intensive care unit patients with concurrent h......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (4)
Medium cut-off (MCO) dialyzers were designed to provide better clearance of uremic toxins. We conducted a meta-analysis comparing MCO with high-flux (......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (2)
The aim of this study was to delve into whether beta-2 microglobulin could assess all-cause mortality in patients with chronic kidney disease. PubMed ......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (1)
Cardiovascular diseases (CVD) are common in maintenance hemodialysis (MHD) patients, and vascular calcification is associated with the incidence of CV......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (4)
Introduction Early-onset peritonitis (EOP) is a risk factor for mortality in peritoneal dialysis (PD) patients. This study investigates the clinical f......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (5)
Introduction Multiple organ dysfunction syndrome (MODS) with secondary hemophagocytic lymphohistiocytosis (SHLH) causes significant mortality. We aime......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (3)
Aim To evaluate the cognitive function in dialysis patients over 60 years old and identify the contributing factors. Methods A group of elderly dialys......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (6)
Introduction This study aimed to compare the efficacy and safety of citrate and heparin in continuous renal replacement therapy (CRRT) for critically ......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (5)
Introduction This study aimed to investigate whether continuous veno-venous hemodiafiltration (CVVHDF) has a different filter life span and molecular ......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (6)
Introduction The objective of this study was to evaluate the effect of continuity of care on self-management ability and quality of life (QOL) in pati......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (4)
Infection-related hospitalization during the peri-dialysis period (PDP) in patients with end-stage renal disease (ESRD) has received less attention. C......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (6)
Introduction This study evaluated the association between serum cystatin C and residual renal function (RRF) in peritoneal dialysis (PD) patients. Met......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (6)
Introduction Investigation of the prognostic factors in patients with refractory heart failure (HF) undergoing continuous veno-venous hemofiltration (......
期刊： THERAPEUTIC APHERESIS AND DIALYSIS, 2022; 26 (1)
To investigate the relationship between red blood cell distribution width (RDW) and residual renal function (RRF) in patients undergoing continuous am......
